News | August 11, 2009

Medical Technologies International, NASA Johnson Space Center Partner on Cardiovascular Testing for Astronauts

August 11, 2009 – Medical Technologies International Inc. (MTI) said yesterday it is partnering with the NASA Johnson Space Center (JSC) to help clarify and monitor the cardiovascular health of the center’s astronauts and trainees using MTI’s ArterioVision test.

The ArterioVision carotid intima-media thickness (CIMT) test uses ultrasound technology to measure the thickness of the first two layers of the carotid artery wall. The FDA-cleared procedure determines whether there has been a build-up of fats causing the wall to thicken. Wall thickening is the earliest noninvasive indicator of atherosclerosis – the underlying cause of heart attack and stroke. The test provides the “age” of a patient’s arteries based on CIMT, compared to one’s chronological age. ArterioVision is quick and painless, and does not expose patients to radiation.

The ArterioVision procedure was developed using the same imaging technology that NASA originally employed to detect the presence of ice on Mars. ArterioVision is an excellent example of NASA technology coming full circle. Scientists at the NASA Jet Propulsion Laboratory worked with Medical Technologies International to take technology originally used in space, and adapt it for a medical application that will be used to reduce health risks and help save lives.

NASA will use ArterioVision at JSC to monitor the cardiovascular health of astronauts as they train for flight missions. JSC hopes to use the ArterioVision test as a preventive medicine screening tool for its employees, as part of an integrated wellness exam aimed at keeping employees healthy, and thereby reducing costs from lost workdays.

ArterioVision was developed by Medical Technologies International founder and Chairman/CEO Gary F. Thompson in partnership with NASA’s Jet Propulsion Laboratory, the California Institute of Technology, and the Keck School of Medicine at the University of Southern California. The scientists and engineers adapted technology that was originally created at JPL in 1966 to interpret images sent from space. That software, which was invented to process pictures from several missions, including the Voyagers and Mars Reconnaissance Orbiter, forms the foundation for the software used in the ArterioVision CIMT test. Thompson worked with the research team to transfer the technology from the laboratory to physicians’ offices throughout the country.

For more information:

Related Content

Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging| September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
Orange County, Calif. Hospital Adopts Siemens Somatom Force CT for Cardiac Imaging
News | Computed Tomography (CT)| September 12, 2017
Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens...
PURE study may cause revision of fat intake guidelines for cardiology.
Feature | ESC| September 07, 2017
September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of
Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing| September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Overlay Init